The University of Southampton
University of Southampton Institutional Repository

Investigations into the biosynthesis of uroporphyrinogen III from porphobilinogen

Investigations into the biosynthesis of uroporphyrinogen III from porphobilinogen
Investigations into the biosynthesis of uroporphyrinogen III from porphobilinogen

The tetrapolymerisation reaction performed by porphobilinogen deaminase and the subsequent transformation of the linear 1-hydroymethylbilane product, preuroporphyrinogen, into the tetracyclic intermediate uroporphyrinogen III were investigated.

The porphobilinogen deaminase enzyme has been extensively characterised with detailed site directed mutagenesis and X-ray crystallographic studies resulting in a good general understanding of its mechanism of action. In this study several pyrrolic analogues were chemically synthesised by Jack Cheung and their effects on the interaction between porphobilinogen deaminase and its monopyrrolic substrate, porphobilinogen, were determined. Whereas most of these analogues were shown to act as competitive inhibitors, the α,α'-diaminomethyl, α,α'-dihydroxymethyl and α-hydroxymethyl-α'-methyl porphobilinogen analogues were all shown to interact covalently with the enzyme, each forming a stable but reversible enzyme-intermediate complex which blocked the polymerisation reaction. The importance of the α and β substituents are discussed with respect to their role in substrate recognition.

Unlike porphobilinogen deaminase, little is known about the mechanism of action of uroporphyrinogen III synthase. Due to the inherent instability of both the enzyme and its substrate, no site-directed mutagenesis studies have been reported other than the effects of natural mutations in the human enzyme that cause congenital erythropoietic porphyria. For the purpose of the study several mutants of uroporphyrinogen III synthase from Escherichia coli and Bacillus subtilis were generated by site-directed mutagenesis and expressed in Escherichia coli. Three highly conserved residues (tyrosine, serine and threonine) and two highly conserved residues (arginine and glutamic acid) were targeted for detailed investigations. The effects of these mutations on catalysis and the likely roles of each substituted residue are discussed. Initial attempts to crystallise the uroporphyrinogen III synthase enzyme in the presence of a spirolactam inhibitor are currently in progress.

University of Southampton
Leadbetter, Robert Elwyn
Leadbetter, Robert Elwyn

Leadbetter, Robert Elwyn (1997) Investigations into the biosynthesis of uroporphyrinogen III from porphobilinogen. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

The tetrapolymerisation reaction performed by porphobilinogen deaminase and the subsequent transformation of the linear 1-hydroymethylbilane product, preuroporphyrinogen, into the tetracyclic intermediate uroporphyrinogen III were investigated.

The porphobilinogen deaminase enzyme has been extensively characterised with detailed site directed mutagenesis and X-ray crystallographic studies resulting in a good general understanding of its mechanism of action. In this study several pyrrolic analogues were chemically synthesised by Jack Cheung and their effects on the interaction between porphobilinogen deaminase and its monopyrrolic substrate, porphobilinogen, were determined. Whereas most of these analogues were shown to act as competitive inhibitors, the α,α'-diaminomethyl, α,α'-dihydroxymethyl and α-hydroxymethyl-α'-methyl porphobilinogen analogues were all shown to interact covalently with the enzyme, each forming a stable but reversible enzyme-intermediate complex which blocked the polymerisation reaction. The importance of the α and β substituents are discussed with respect to their role in substrate recognition.

Unlike porphobilinogen deaminase, little is known about the mechanism of action of uroporphyrinogen III synthase. Due to the inherent instability of both the enzyme and its substrate, no site-directed mutagenesis studies have been reported other than the effects of natural mutations in the human enzyme that cause congenital erythropoietic porphyria. For the purpose of the study several mutants of uroporphyrinogen III synthase from Escherichia coli and Bacillus subtilis were generated by site-directed mutagenesis and expressed in Escherichia coli. Three highly conserved residues (tyrosine, serine and threonine) and two highly conserved residues (arginine and glutamic acid) were targeted for detailed investigations. The effects of these mutations on catalysis and the likely roles of each substituted residue are discussed. Initial attempts to crystallise the uroporphyrinogen III synthase enzyme in the presence of a spirolactam inhibitor are currently in progress.

This record has no associated files available for download.

More information

Published date: 1997

Identifiers

Local EPrints ID: 463237
URI: http://eprints.soton.ac.uk/id/eprint/463237
PURE UUID: ad8ca85a-e128-4195-a4f9-5c9baaf99a28

Catalogue record

Date deposited: 04 Jul 2022 20:47
Last modified: 04 Jul 2022 20:47

Export record

Contributors

Author: Robert Elwyn Leadbetter

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×